The potential benefits of GLP-1 drugs continue to expand.
New research has shown that weight loss and diabetes drugs are officially known as glucagon-like peptide 1 receptor agonists. – is associated with a reduced risk of Some cancersespecially for women.
Researchers from Indiana University and the University of Florida analyzed the incidence of 14 cancers Obese adults GLP-1 was prescribed and they were compared with cancer rates of non-user.
Weight Loss Doctors Share How GLP-1 Affects the Illness
The study, published in Jama Oncology, examined health record data from 2014 to 2024. Anti-obesity drugs There was no previous history of cancer.
Of the 86,632 individuals sampled, 68.2% of them were women, and the results show that there is a “significantly lower overall cancer risk” among those taking GLP-1.
Taking GLP-1 was associated with a reduced risk of endometrial, ovarian, and meningioma cancer, among other things.
Although the results were mostly positive, this study found a link to increased risk with GLP-1 use Kidney cancerthe researchers pointed out.
Weight loss pills could add years to American lives, researchers project
The researchers concluded that long-term follow-up is necessary to clarify the mechanisms and clinical implications underlying these findings.
Dr. Brianth Lomovitz, director of gynecological oncology at Mount Sinai Medical Center in Miami Beach, Florida, was not involved in the study, but responded to the findings in an interview with Fox News Digital.
Slomobits treating women with endometrium Ovarian cancerplease note that these are frequently Obesity-driven cancer And this link between GLP-1 and risk reduction is “not surprising.”
“opportunity [for GLP-1s] It’s ridiculous and if the research is positive, it’s about changing the game. See it with other illnesses,” he said.
Common weight loss medications can relieve painful arthritis symptoms, doctors report
Some of these are estrogen-driven cancers, and estrogen is produced by adipocytes, the gynecological oncologist noted.
“Weight loss physically reduces the amount of fat cells and the amount of estrogen production,” he said. “By losing weight, this class of medication helps reduce some of the inflammation we see. Insulin resistance. ”
Slomovitz does not prescribe these medications to patients, but he “strongly recommends them.”
The patient is Weight loss doctor Or, primary care physicians who can closely monitor these medications while taking them suggested that they are at risk for certain side effects, especially nausea and pancreatitis.
Slomovitz said he specifically recommends GLP-1 in patients with endometrial cancer after treatment.
“I told them, ‘You’ve hit cancer. Now we need to understand what we can do to help you live longer,” he said. “I’m honestly saying that they don’t die of cancer, they’re obese, Their diabetestheir heart disease [might lead to death]. ”
Along with Cancer’s five years of surveillance, Slomovitz recommends seeing a doctor to lose weight.
The doctor added that More research It is necessary to see if GLP-1, or general weight loss, can reduce the risk of cancer recurrence in survivors.
One of the “exciting” possibilities of these drugs is Maintain the birth rate In women, Slomovitz pointed out by reducing lesions in the reproductive organs without the need for surgical procedures such as hysterectomy.
Click here to sign up for our health newsletter
Ongoing research has examined how GLP-1 affects hormonal conditions in women, such as polycystic ovarian syndrome (PCOS), which can help reduce obesity and infertility.
“An anecdote, what I see from patients too – they’re light, feel better, willing to go to the gym, motivated to exercise, they’re more motivated [adopt] a Healthier lifestylebecause they see what it can feel lighter,” he told Fox News Digital.
For health articles, please visit foxnews.com/health
“[GLP-1s] We are definitely here to be here…and the next generation will continue to do great things for our patients if they follow this trajectory. ”
